Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Goldman, Jennifer G.
Williams‐Gray, Caroline
Barker, Roger A.
Duda, John E.
and
Galvin, James E.
2014.
The spectrum of cognitive impairment in Lewy body diseases.
Movement Disorders,
Vol. 29,
Issue. 5,
p.
608.
Segura, Bàrbara
Baggio, Hugo César
Marti, Maria Josep
Valldeoriola, Francesc
Compta, Yaroslau
Garcia‐Diaz, Anna Isabel
Vendrell, Pere
Bargallo, Núria
Tolosa, Eduardo
and
Junque, Carme
2014.
Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
Movement Disorders,
Vol. 29,
Issue. 12,
p.
1495.
Bott, Nicholas T.
Johnson, Erica T.
Schuff, Norbert
Galifianakis, Nicholas
Subas, Trishna
Pollock, Jessica
Pressman, Peter
Kramer, Joel H.
and
Possin, Katherine L.
2014.
Sensitive measures of executive dysfunction in non-demented Parkinson's disease.
Parkinsonism & Related Disorders,
Vol. 20,
Issue. 12,
p.
1430.
Marras, Connie
Tröster, Alexander I.
Kulisevsky, Jaime
and
Stebbins, Glenn T.
2014.
The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease.
Movement Disorders,
Vol. 29,
Issue. 5,
p.
584.
Hershey, Linda A.
and
Peavy, Guerry M.
2015.
Cognitive decline in Parkinson disease.
Neurology,
Vol. 85,
Issue. 15,
p.
1268.
Pigott, Kara
Rick, Jacqueline
Xie, Sharon X.
Hurtig, Howard
Chen-Plotkin, Alice
Duda, John E.
Morley, James F.
Chahine, Lama M.
Dahodwala, Nabila
Akhtar, Rizwan S.
Siderowf, Andrew
Trojanowski, John Q.
and
Weintraub, Daniel
2015.
Longitudinal study of normal cognition in Parkinson disease.
Neurology,
Vol. 85,
Issue. 15,
p.
1276.
Pirogovsky-Turk, Eva
Filoteo, J. Vincent
Litvan, Irene
and
Harrington, Deborah L.
2015.
Structural MRI Correlates of Episodic Memory Processes in Parkinson’s Disease Without Mild Cognitive Impairment.
Journal of Parkinson's Disease,
Vol. 5,
Issue. 4,
p.
971.
Leaver, Katherine
and
Poston, Kathleen L.
2015.
Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson’s disease patients? A Systematic Review.
Neuropsychology Review,
Vol. 25,
Issue. 4,
p.
411.
Yilmaz, Rezzak
Gräber, Susanne
Roeben, Benjamin
Suenkel, Ulrike
Thaler, Anna-Katharina von
Heinzel, Sebastian
Metzger, Florian G.
Eschweiler, Gerhard W.
Maetzler, Walter
Berg, Daniela
and
Liepelt-Scarfone, Inga
2016.
Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease.
Frontiers in Aging Neuroscience,
Vol. 8,
Issue. ,
de Vent, Nathalie R.
Agelink van Rentergem, Joost A.
Schmand, Ben A.
Murre, Jaap M. J.
and
Huizenga, Hilde M.
2016.
Advanced Neuropsychological Diagnostics Infrastructure (ANDI): A Normative Database Created from Control Datasets.
Frontiers in Psychology,
Vol. 7,
Issue. ,
Vlagsma, T. T.
Koerts, J.
Fasotti, L.
Tucha, O.
van Laar, T.
Dijkstra, H.
and
Spikman, J. M.
2016.
Parkinson's patients’ executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?.
Neuropsychological Rehabilitation,
Vol. 26,
Issue. 2,
p.
216.
Yang, Yang
Tang, Bei-sha
and
Guo, Ji-feng
2016.
Parkinson’s Disease and Cognitive Impairment.
Parkinson's Disease,
Vol. 2016,
Issue. ,
p.
1.
Cooney, Jeffrey W.
and
Stacy, Mark
2016.
Neuropsychiatric Issues in Parkinson’s Disease.
Current Neurology and Neuroscience Reports,
Vol. 16,
Issue. 5,
Poston, Kathleen L.
YorkWilliams, Sophie
Zhang, Kai
Cai, Weidong
Everling, David
Tayim, Fadi M.
Llanes, Seoni
and
Menon, Vinod
2016.
Compensatory neural mechanisms in cognitively unimpaired Parkinson disease.
Annals of Neurology,
Vol. 79,
Issue. 3,
p.
448.
Yilmaz, R.
Behnke, S.
Liepelt‐Scarfone, I.
Roeben, B.
Pausch, C.
Runkel, A.
Heinzel, S.
Niebler, R.
Suenkel, U.
Eschweiler, G. W.
Maetzler, W.
and
Berg, D.
2016.
Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults.
European Journal of Neurology,
Vol. 23,
Issue. 5,
p.
973.
Sales, A
Pitarque, A
Escudero, J
Satorres, E
and
Meléndez, J. C
2017.
Can there be learning potential in Parkinson’s disease? A comparison with healthy older adults.
Developmental Neuropsychology,
Vol. 42,
Issue. 7-8,
p.
460.
Volta, Mattia
Beccano-Kelly, Dayne A
Paschall, Sarah A
Cataldi, Stefano
MacIsaac, Sarah E
Kuhlmann, Naila
Kadgien, Chelsie A
Tatarnikov, Igor
Fox, Jesse
Khinda, Jaskaran
Mitchell, Emma
Bergeron, Sabrina
Melrose, Heather
Farrer, Matthew J
and
Milnerwood, Austen J
2017.
Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice.
eLife,
Vol. 6,
Issue. ,
Agelink van Rentergem, Joost A.
Murre, Jaap M. J.
Huizenga, Hilde M.
and
Smith, Alastair
2017.
Multivariate normative comparisons using an aggregated database.
PLOS ONE,
Vol. 12,
Issue. 3,
p.
e0173218.
Heinzel, Sebastian
Lerche, Stefanie
Maetzler, Walter
and
Berg, Daniela
2017.
Global, Yet Incomplete Overview of Cohort Studies in Parkinson’s disease.
Journal of Parkinson's Disease,
Vol. 7,
Issue. 3,
p.
423.
Bezdicek, Ondrej
Stepankova, Hana
Axelrod, Bradley N.
Nikolai, Tomas
Sulc, Zdenek
Jech, Robert
Růžička, Evžen
and
Kopecek, Miloslav
2017.
Clinimetric validity of the Trail Making Test Czech version in Parkinson’s disease and normative data for older adults.
The Clinical Neuropsychologist,
Vol. 31,
Issue. sup1,
p.
42.